Molson Coors buys 8.5% stake in Fever-Tree as part of US tie-up

Molson Coors non alc portfolio selection

Fever-Tree co-founder and CEO Tim Warrillow called it a ‘transformational step’

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW